×
About 8,553 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  2,187 results

A 9-year-old girl was evaluated for a week-long history of rash on the feet
https://www.mdedge.com/pediatrics/article/257051/dermatology/9-year-old-girl-was-evaluated-week-long-history-rash-feet
Catalina Matiz, MD, Alix Jessika Valderrama, MD

Aug 16th, 2022 - A complete body examination failed to reveal any other lesions suggestive of a fungal infection. A blood count and urinalysis were within normal limits.

The impact of pharmacist involvement on immunization uptake and other outcomes: An upda...
https://doi.org/10.1016/j.japh.2022.06.008
Journal of the American Pharmacists Association : JAPhA; Le LM, Veettil SK et. al.

Aug 13th, 2022 - The underutilization of immunization services remains a big public health concern. Pharmacists can address this concern by playing an active role in immunization administration. We performed a systematic review and meta-analysis to assess the impa...

Association between vitamin D and incident herpes zoster: a UK Biobank study.
https://doi.org/10.3399/BJGP.2021.0623
The British Journal of General Practice : the Journal of ... Lin LY, Mathur R et. al.

Aug 9th, 2022 - Vitamin D has immunomodulatory effects, but any association with herpes zoster (HZ) is unclear. To explore the association between vitamin D status and risk of incident HZ in adults in the UK. A cohort study involving participants of UK Biobank (a...

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
https://doi.org/10.1056/NEJMoa2118024
The New England Journal of Medicine; Werth VP, Furie RA et. al.

Aug 9th, 2022 - Blood dendritic cell antigen 2 (BDCA2) is a receptor that is exclusively expressed on plasmacytoid dendritic cells, which are implicated in the pathogenesis of lupus erythematosus. Whether treatment with litifilimab, a humanized monoclonal antibod...

A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
https://clinicaltrials.gov/ct2/show/NCT05492591

Aug 8th, 2022 - This trial is a multicenter, randomized, active drug-controlled, dose-finding phase II clinical study. A total of 5 experimental groups and 1 positive drug control group were set up to evaluate the efficacy, optimal dose and efficacy trend of mult...

see more →

Guidelines  5 results

Management of herpesvirus reactivations in patients with solid tumours and hematologic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810475
Annals of Hematology; Henze L, Buhl C et. al.

Jan 8th, 2022 - Clinical reactivations of herpes simplex virus or varicella zoster virus occur frequently among patients with malignancies and manifest particularly as herpes simplex stomatitis in patients with acute leukaemia treated with intensive chemotherapy ...

European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by...
https://doi.org/10.1111/jdv.13957
Journal of the European Academy of Dermatology and Venere... Werner RN, Nikkels AF et. al.

Nov 3rd, 2016 - Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration...

Interventional management of neuropathic pain: NeuPSIG recommendations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484720
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization ...
https://www.ncbi.nlm.nih.gov/pubmed/18528318
MMWR. Recommendations and Reports : Morbidity and Mortali... Harpaz R, Ortega-Sanchez IR et. al.

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

see more →

Drugs  571 results see all →

Clinicaltrials.gov  157 results

A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
https://clinicaltrials.gov/ct2/show/NCT05492591

Aug 8th, 2022 - This trial is a multicenter, randomized, active drug-controlled, dose-finding phase II clinical study. A total of 5 experimental groups and 1 positive drug control group were set up to evaluate the efficacy, optimal dose and efficacy trend of mult...

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Aug 5th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

NPC-06 to Pain Associated With Acute Herpes Zoster
https://clinicaltrials.gov/ct2/show/NCT05480553

Aug 2nd, 2022 - The eligible patients will be randomized into two groups, and will receive NPC-06 or placebo.

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior...
https://clinicaltrials.gov/ct2/show/NCT04091451

Jul 25th, 2022 - The study will be conducted in 2 epochs: Epoch 001- starting from visit day 1, followed by visit month 2 and then Visit 3 at one month post last vaccination (Month 3). Epoch 002- Starting with monthly contact after Visit 3 (Month 3) and ending at ...

The Efficacy and Safety of Intradermal Acupuncture for Acute Herpes Zoster
https://clinicaltrials.gov/ct2/show/NCT05348382

Jul 18th, 2022 - This randomized controlled trial will enroll 72 eligible patients with acute herpes zoster. Participants who are confirmed eligibility will be randomly allocated to either the IDA group or the sham IDA group in a 1:1 ratio. The duration of the tri...

see more →

News  493 results

A 9-year-old girl was evaluated for a week-long history of rash on the feet
https://www.mdedge.com/pediatrics/article/257051/dermatology/9-year-old-girl-was-evaluated-week-long-history-rash-feet
Catalina Matiz, MD, Alix Jessika Valderrama, MD

Aug 16th, 2022 - A complete body examination failed to reveal any other lesions suggestive of a fungal infection. A blood count and urinalysis were within normal limits.

Trending Clinical Topic: Dementia
https://www.medscape.com/viewarticle/975899

Jul 15th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook.  In 2019, the...

Trending Clinical Topic: Dementia
https://reference.medscape.com/viewarticle/975899

Jul 15th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook.  In 2019, the...

Zoster vaccination does not appear to increase flare risk in patients with immune-mediated inflammatory disease
https://www.mdedge.com/rheumatology/article/256182/rheumatoid-arthritis/zoster-vaccination-does-not-appear-increase-flare
Louise Gagnon

Jul 11th, 2022 - A retrospective investigation using medical claims data found no elevated risk of disease flares in patients with immune-mediated inflammatory diseases (IMIDs) who received the recombinant zoster vaccine (RZV), according to research published in A.

Zoster Vaccine Does Not Appear to Increase Flares in Patients With Immune-Mediated Inflammatory Disease
https://www.medscape.com/viewarticle/976934

Jul 11th, 2022 - A retrospective investigation using medical claims data found no elevated risk of disease flares in patients with immune-mediated inflammatory diseases (IMIDs) who received the recombinant zoster vaccine (RZV), according to research published in A...

see more →

Patient Education  8 results see all →